InSilico Medicine Presents advances in deep learning for drug discovery and aging research

Loading video…VIDEO: On Tuesday, Jan. 12th at 17.15 PM InSilico Medicine will present an update on recent advances in applying signaling pathway activation analysis and deep learning to drug discovery and drug… view more Credit: InSilico Medicine, Inc. Aging research is a very controversial area with many failed claims and promises and in order to establish the proof of concept of its approach, InSilico Medicine decided to build a sustainable business model providing pathway activation analysis and machine learning services to pharmaceutical companies, academic and clinical institutions helping drive innovation in many areas of research. “Our mission is to extend healthy human longevity and we spent several years developing a sustainable model to enable the company to effectively use massive heterogeneous biological data sets for drug discovery, biomarker development and personalized…


Link to Full Article: InSilico Medicine Presents advances in deep learning for drug discovery and aging research